2014 Publications

2017|2016|2015|2014|2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | < 1999

  • Yurist-Doutsch S., Arrieta M.C., Vogt S.L., Finlay B.B. Gastrointestinal microbiota-mediated control of enteric pathogens. Annu Rev Genet. 2014 Nov 23;48:361-82.
  • Roberts M.E., Bishop J.L., Fan X., Beer J.L., Kum W.W., Krebs D.L., Huang M., Gill N., Priatel J.J., Finlay B.B., Harder K.W.  Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogens. J Immunol. 2014 Nov 15;193(10):5249-63.
  • Valdez Y., Brown E.M., Finlay B.B. Influence of the microbiota on vaccine effectiveness. Trends Immunol. 2014 Nov;35(11):526-537. Review.
  • Collins J.W., Keeney K.M., Crepin V.F., Rathinam V.A., Fitzgerald K.A., Finlay B.B., Frankel G. Citrobacter rodentium: infection, inflammation and the microbiota. Nat Rev Microbiol. 2014 Sep;12(9):612-23. Review.
  • Antunes L.C., McDonald J.A., Schroeter K., Carlucci C., Ferreira R.B., Wang M., Yurist-Doutsch S., Hira G., Jacobson K., Davies J., Allen-Vercoe E., Finlay B.B. Antivirulence activity of the human gut metabolome. MBio. 2013 Jul 29;5(4):e01183-14.
  • Reynolds L.A., Smith K.A., Filbey K.J., Harcus Y., Hewitson J.P., Redpath S.A., Valdez Y., Yebra M.J., Finlay B.B., Maizels R.M. Commensal-pathogen interactions in the intestinal tract: lactobacilli promote infection with, and are promoted by, helminth parasites. Gut Microbes. 2014 Jul 1;5(4):522-32.
  • Mattos K.A., Oliveira V.C., Berredo-Pinho M., Amaral J.J., Antunes L.C., Melo R.C., Acosta C.C., Moura D.F., Olmo R., Han J., Rosa P.S., Almeida P.E., Finlay B.B., Borchers C.H., Sarno E.N., Bozza P.T., Atella G.C., Pessolani M.C.  (Feb) Mycobacterium leprai intracellular survival relies on cholestol accumulation in infected macrophages: a potential target for new drugs for leprosy treamtment. Cell Microbiol. 2014 Jun;16(6):797-815
  • Keeney K.M., Yurist-Doutsch S., Arrieta M.C., Finlay B.B.  Effects of antibiotics on Human Microbiota and Subsequent Disease. Annu Rev Microbiol. 2014 Jun 2;68:217-35.
  • Yu H.B., Croxen M.A., Marchiando A.M., Ferreira R.B., Cadwell K., Foster L.J., Finlay B.B.  Autophagy Facilitates Salmonella Replication in HeLa Cells.  MBio. 2014 Mar 11;5(2) e00865-14.
  • Kumar N.S., Dullaghan E.M., Finlay B.B., Gong H., Reiner N.E., Jon Palul Selvam J., tThorson L.M., Campbell S., Vitko N., Richardson A.R., Zoraghi R., Yung R.N.  Discovery and optimization of a new class of pyruvate kinase inhibitors as potential therapeutics for the treatment of methicillin-resistant Staphylococcus aureus infections. Bioorg Med Chem. 2014 Mar 1;22(5):1708-25.
  • Wlodarska M., Thaiss C.A., Nowarski R., Henao-Mejia J., Zhang J.P., Brown E.M., Frankel G., Levy M., Katz M.N., Philbrick W.M., Elinav E.*, Flavell R.A.*, Finlay B.B.* NLRP6 Inflammasome Orchestrates the Colonic Host-Microbial Interface by Regulating Goblet Cell Mucus Secretion.  Cell. 2014 Feb 27;156(5)1045-59. * equal contributors
  • Marshall N.C., Finlay B.B. Targeting the type III secretion system to treat bacterial infections.  Expert Opin Ther Targets. 2014 Feb;18(2):137-52.
  • Brown E.M., Sadarangani M., Finlay B.B. (Jan) 2014. Erratum: The role of the immune system in governing host-microbe interactions in the intestine.  Nat Immunol. 2014 Jan 21;15(2):205.